U G R Schulz1, E Flossmann, J M Francis, J N Redgrave, P M Rothwell. 1. Department of Clinical Stroke Prevention Research Unit, University of Neurology, Radcliffe Infirmary, and Centre for Clinical Magnetic Resonance Research, John Radcliffe Hospital, Oxford, OX2 6HE, United Kingdom.
Abstract
INTRODUCTION: Diffusion-weighted imaging (DWI) is mainly used in acute stroke, and signal evolution in the acute phase has been studied extensively. However, patients with a minor stroke frequently present late. Recent studies suggest that DWI may be helpful at this stage, but only very few published data exist on the evolution of the DW-signal in the weeks and months after a stroke. We performed a follow-up study of DWI in the late stages after a minor stroke. METHODS: 28 patients who presented 48 hours to 14 days after a minor stroke underwent serial MRI at baseline, 4 weeks, 8 weeks, 12 weeks, 6 months and>or=9 months after their event. Signal intensity within the lesion was determined on T2-weighted images, DW-images and the Apparent Diffusion Coefficient (ADC) map at each time-point, and ratios were calculated with contralateral normal values (T2r, DWIr, ADCr). RESULTS: T2r was increased in all patients from the beginning, and showed no clear temporal evolution. ADCr normalized within 8 weeks in 83% of patients, but still continued to increase for up to 6 months after the event. The DW-signal decreased over time, but was still elevated in 6 patients after>or=6 months. The evolution of ADCr and DWIr showed statistically highly significant inter-individual variation (p<0.0001), which was not accounted for by age, sex, infarct size or infarct location. CONCLUSION: The ADC and the DW-signal may continue to evolve for several months after a minor ischaemic stroke. Signal evolution is highly variable between individuals. Further studies are required to determine which factors influence the evolution of the ADC and the DW-signal.
INTRODUCTION: Diffusion-weighted imaging (DWI) is mainly used in acute stroke, and signal evolution in the acute phase has been studied extensively. However, patients with a minor stroke frequently present late. Recent studies suggest that DWI may be helpful at this stage, but only very few published data exist on the evolution of the DW-signal in the weeks and months after a stroke. We performed a follow-up study of DWI in the late stages after a minor stroke. METHODS: 28 patients who presented 48 hours to 14 days after a minor stroke underwent serial MRI at baseline, 4 weeks, 8 weeks, 12 weeks, 6 months and>or=9 months after their event. Signal intensity within the lesion was determined on T2-weighted images, DW-images and the Apparent Diffusion Coefficient (ADC) map at each time-point, and ratios were calculated with contralateral normal values (T2r, DWIr, ADCr). RESULTS: T2r was increased in all patients from the beginning, and showed no clear temporal evolution. ADCr normalized within 8 weeks in 83% of patients, but still continued to increase for up to 6 months after the event. The DW-signal decreased over time, but was still elevated in 6 patients after>or=6 months. The evolution of ADCr and DWIr showed statistically highly significant inter-individual variation (p<0.0001), which was not accounted for by age, sex, infarct size or infarct location. CONCLUSION: The ADC and the DW-signal may continue to evolve for several months after a minor ischaemic stroke. Signal evolution is highly variable between individuals. Further studies are required to determine which factors influence the evolution of the ADC and the DW-signal.
Authors: M E Moseley; Y Cohen; J Mintorovitch; L Chileuitt; H Shimizu; J Kucharczyk; M F Wendland; P R Weinstein Journal: Magn Reson Med Date: 1990-05 Impact factor: 4.668
Authors: M G Lansberg; V N Thijs; M W O'Brien; J O Ali; A J de Crespigny; D C Tong; M E Moseley; G W Albers Journal: AJNR Am J Neuroradiol Date: 2001-04 Impact factor: 3.825
Authors: James D Eastwood; Stefan T Engelter; James F MacFall; David M Delong; James M Provenzale Journal: AJNR Am J Neuroradiol Date: 2003-04 Impact factor: 3.825
Authors: P M Rothwell; A J Coull; M F Giles; S C Howard; L E Silver; L M Bull; S A Gutnikov; P Edwards; D Mant; C M Sackley; A Farmer; P A G Sandercock; M S Dennis; C P Warlow; J M Bamford; P Anslow Journal: Lancet Date: 2004-06-12 Impact factor: 79.321
Authors: Annemieke Ter Telgte; Ashley A Scherlek; Yael D Reijmer; Andre J van der Kouwe; Thijs van Harten; Marco Duering; Brian J Bacskai; Frank-Erik de Leeuw; Matthew P Frosch; Steven M Greenberg; Susanne J van Veluw Journal: Acta Neuropathol Date: 2020-02-27 Impact factor: 17.088
Authors: Annemieke Ter Telgte; Kim Wiegertjes; Benno Gesierich; Brendon Sri Baskaran; José P Marques; Hugo J Kuijf; David G Norris; Anil M Tuladhar; Marco Duering; Frank-Erik de Leeuw Journal: JAMA Neurol Date: 2020-05-01 Impact factor: 18.302
Authors: Annemieke Ter Telgte; Kim Wiegertjes; Anil M Tuladhar; Marlies P Noz; José P Marques; Benno Gesierich; Mathias Huebner; Henk-Jan Mm Mutsaerts; Suzette E Elias-Smale; Marie-José Beelen; Stefan Ropele; Roy Pc Kessels; Niels P Riksen; Catharina Jm Klijn; David G Norris; Marco Duering; Frank-Erik de Leeuw Journal: Eur Stroke J Date: 2018-05-09
Authors: Annemieke Ter Telgte; Kim Wiegertjes; Benno Gesierich; José P Marques; Mathias Huebner; Jabke J de Klerk; Floris H B M Schreuder; Miguel A Araque Caballero; Hugo J Kuijf; David G Norris; Catharina J M Klijn; Martin Dichgans; Anil M Tuladhar; Marco Duering; Frank-Erik de Leeuw Journal: Ann Neurol Date: 2019-08-12 Impact factor: 10.422
Authors: Anne L Abbott; Mauro Silvestrini; Raffi Topakian; Jonathan Golledge; Alejandro M Brunser; Gert J de Borst; Robert E Harbaugh; Fergus N Doubal; Tatjana Rundek; Ankur Thapar; Alun H Davies; Anthony Kam; Joanna M Wardlaw Journal: Front Neurol Date: 2017-10-18 Impact factor: 4.003